Company Endo Inc.

Equities

NDOI

US29290D1173

Pharmaceuticals

Market Closed - OTC Markets 14:30:10 05/07/2024 BST 5-day change 1st Jan Change
28.5 USD +0.88% Intraday chart for Endo Inc. +0.88% 0.00%

Business Summary

Endo, Inc. is a diversified specialty pharmaceutical company, which is engaged in transforming insights into life-enhancing therapies. It provides a comprehensive range of healthcare products, designed to meet the needs of patients across the United States. Its product categories include specialty medicines, sterile injectables, and generics. Its products include ADRENALIN CHLORIDE solution; ADREN ALIN; ALISKIREN tablets; ALLOPURINOL tablets, USP; ALPRAZOLAM ORALLY DISINTEGRATING tablets, USP CIV; ALVIMOPAN capsules; AMILORIDE HYDROCHLORIDE tablets, USP; APLISOL; ARGATROBAN injection; ASPIRIN & EXTENDED RELEASE DIPYRIDAMOLE capsules; AVEED; BACLOFEN TABLETS, USP; BENZTROPINE MESYLATE tablets, USP; BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE capsules; BIVALIRUDIN injection; BREVITAL; BUPRENORPHINE HYDROCHLORIDE injection CIII; BUTALBITAL and ACETAMINOPHEN tablets; CALCITONIN SALMON injection, USP SYNTHETIC, and CANDESARTAN CILEXETIL tablets.